Allurion Issues Warrants for 1.42M Shares at $8.10 Exercise Price
Ticker: ALURW · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1964979
Complexity: simple
Sentiment: neutral
Topics: warrants, equity-financing, dilution-risk
TL;DR
**Allurion issued warrants for 1.42M shares at $8.10, watch for potential dilution.**
AI Summary
Allurion Technologies, Inc. filed an 8-K on January 8, 2024, to report the issuance of warrants to purchase 1,420,455 shares of common stock, each at an exercise price of $8.10 per share. This matters to investors because the exercise of these warrants could dilute the value of existing shares by increasing the total number of outstanding shares, potentially impacting the stock price.
Why It Matters
The issuance of these warrants could lead to future share dilution if exercised, potentially impacting the per-share value for current stockholders. It signals a potential increase in the company's capital base if the warrants are exercised.
Risk Assessment
Risk Level: medium — The issuance of warrants introduces potential future dilution, which is a medium-level risk for existing shareholders.
Analyst Insight
A smart investor would monitor the company's stock price relative to the $8.10 warrant exercise price to gauge the likelihood of warrant exercise and potential future dilution. They should also consider the company's capital needs and how this financing fits into its overall strategy.
Key Numbers
- 1,420,455 — Shares under warrant (Represents the total number of common stock shares that can be purchased if all warrants are exercised.)
- $8.10 — Warrant exercise price (This is the price at which each warrant holder can buy one share of common stock.)
- $0.0001 — Common stock par value (The nominal value assigned to each share of common stock.)
Key Players & Entities
- Allurion Technologies, Inc. (company) — the registrant filing the 8-K
- 1,420,455 (dollar_amount) — number of shares of common stock purchasable via warrants
- $8.10 (dollar_amount) — exercise price per share for the warrants
- January 8, 2024 (dollar_amount) — date of earliest event reported and filing date
Forward-Looking Statements
- The exercise of these warrants will lead to an increase in Allurion's outstanding shares. (Allurion Technologies, Inc.) — medium confidence, target: Within 1-3 years (typical warrant lifespan)
- The company's cash reserves will increase if a significant portion of the warrants are exercised. (Allurion Technologies, Inc.) — high confidence, target: Upon warrant exercise
FAQ
What is the specific event reported in this 8-K filing by Allurion Technologies, Inc.?
Allurion Technologies, Inc. reported the issuance of warrants to purchase 1,420,455 shares of common stock, each at an exercise price of $8.10 per share, on January 8, 2024.
What is the exercise price for each share of common stock under these warrants?
The exercise price for each share of common stock under these warrants is $8.10.
How many shares of common stock are purchasable through the warrants mentioned in the filing?
A total of 1,420,455 shares of common stock are purchasable through the warrants.
What is the par value of Allurion Technologies, Inc.'s common stock?
The par value of Allurion Technologies, Inc.'s common stock is $0.0001 per share.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 8, 2024.
Filing Stats: 560 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-01-08 08:00:10
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ALUR The New York Stock E
- $8.10 — mon stock, each at an exercise price of $8.10 per share of common stock ALUR WS T
Filing Documents
- alur-20240108.htm (8-K) — 43KB
- alur-ex99_1.htm (EX-99.1) — 29KB
- 0000950170-24-002703.txt ( ) — 222KB
- alur-20240108.xsd (EX-101.SCH) — 45KB
- alur-20240108_htm.xml (XML) — 6KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 8, 2024, Allurion Technologies, Inc. issued a press release announcing selected preliminary financial results for the quarter and year ended December 31, 2023. The full text of that press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d)Exhibits Exhibit Description 99.1 Press Release issued by the registrant on January 8, 2024 furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Allurion Technologies, Inc. Date: January 8, 2024 By: /s/ Shantanu Gaur Shantanu Gaur Chief Executive Officer